Ticker
DTILCompany Name
PRECISION BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 108.93M | $ 84.81M | 77.86% |
3/31/2025 | $ 124.41M | $ 99.79M | 80.21% |
12/31/2024 | $ 136.39M | $ 108.47M | 79.53% |
9/30/2024 | $ 153.26M | $ 121.33M | 79.17% |
6/30/2024 | $ 165.8M | $ 123.57M | 74.53% |
3/31/2024 | $ 184.74M | $ 137.77M | 74.57% |
12/31/2023 | $ 159.78M | $ 116.68M | 73.02% |
9/30/2023 | $ 164.34M | $ 122.23M | 74.38% |
6/30/2023 | $ 181.7M | $ 137.79M | 75.84% |
3/31/2023 | $ 204.5M | $ 158.13M | 77.33% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for PRECISION BIOSCIENCES INC is calculated as follows: CashnEq [ $ 104.15M ] / Assets [ $ 168.69M ]
(=) Cash to Assets [ 61.74% ]
Minimum
Dec 31, 2020
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.71% |
average | 9.76% |
median | 6.41% |
std | 9.51% |